4//SEC Filing
ANDERSON ELIZABETH M 4
Accession 0001610717-25-000268
CIK 0001628171other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:24 PM ET
Size
7.5 KB
Accession
0001610717-25-000268
Insider Transaction Report
Form 4
ANDERSON ELIZABETH M
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-26+11,574→ 11,574 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (11,574 underlying) - Award
Common Stock
2025-06-26+3,142→ 23,215 total
Holdings
- 26,990(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by David W. Anderson 1996 Irrevocable Trust.
- [F2]Includes 3,142 Restricted Stock Units.
- [F3]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001758247
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:24 PM ET
- Size
- 7.5 KB